Organizing Healthcare for Optimal Acute Ischemic Stroke Treatment

Abstract

Stroke is a major health-care problem that represents a leading cause of death and also the top cause of disability in adulthood. In recent years there has been a significant paradigm shift in treatments for acute ischemic stroke to favor earlier reperfusion therapy, mainly using the systemic infusion of recombinant tissue plasminogen activator. Subsequent trials found that combining this treatment with endovascular therapy was effective in selected patients. The increased complexity of acute stroke treatments has resulted in a substantial reorganization of stroke care. This review reports on the evolution of acute ischemic stroke treatment and describes the main organizational models based on the hub-and-spoke system. The lack of evidence for comparisons of the effectiveness of different paradigms means that some decision-analysis models predicting the best organizational pathways are also reported, with a particular emphasis on the workflow timing in the prehospital and in-hospital settings. Major benchmarks and performance measures are also reported, focusing on the timing of interventions and rates of process indicators. Finally, future directions are illustrated, including using telemedicine for stroke, mobile stroke units, and artificial intelligence and automated machines to produce software for detecting large-vessel occlusion. cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. JCN

Pathway Design for Acute Stroke Care in the Era of Endovascular Thrombectomy

“…In recent years, various modeling methods have emerged to study organization of acute stroke care before or substituting randomized clinical trials (RCTs). 68,69 Clearly, RCTs can put specific interventions to the test in a real-life care system. The RACECAT trial (Transfer to the Local Stroke Center Versus Direct Transfer to Endovascular Center of Acute Stroke Patients With Suspected Large Vessel Occlusion in the Catalan Territory) is one such RCT comparing the drip-and-ship and mothership models in Catalonia, Spain.…”

A large-scale histological investigation gives insight into the structure of ischemic stroke thrombi

“…The severity of stroke can vary; in Europe it is the second most common cause of death 5 but even if the patient recovers, rehabilitation can take many months, or even years, and some individuals have to learn to live with permanent disabilities as a result of the stroke 2 . The best outcome for the patient is achieved if the blood flow is restored as promptly as possible 6 . European guidelines indicate that treatment for ischemic stroke should occur within the first 4.5 h of the onset of symptoms 3 .…”

“…It is thought that this may be related to the great heterogeneity that is present in the stroke-causing thrombi that could make a clot more, or less, susceptible to degradation by rtPA or affect the likelihood of successful retrieval. Understanding the thrombus composition and structure could lead to more targeted and effective treatments for stroke 6 .…”

Know the Risk: Stroke With Patent Foramen Ovale

“…CT angiography (CTA) of the head and neck establishes if there is a large vessel occlusion where endovascular intervention would be of use and further delineation of candidacy ensues [2]. A complete workup should entail a stroke center of excellence, ideally with an on-site neurology team, but this is not always possible in remote areas of the country and patient care should otherwise be optimized [9]. A transthoracic echocardiogram (TTE) with Doppler and bubbles assesses for an embryologic lack of closure in the cardiac membrane between the top two chambers of the heart or atria [10].…”